Itaú BBA upgraded XP Inc. stock to Outperform from Market Perform, signaling a more positive outlook, but set a price target of $22, below the current trading price of $28.15. Analyst opinions on XP Inc. remain mixed, with an average Moderate Buy rating and price targets ranging around $23.50. The stock recently hit a 52-week high near $29, reflecting strong recent gains despite some inconsistencies in reported trading figures. This mixed sentiment highlights uncertainty about the stock's near-term valuation despite recent momentum.
XP Inc. stock is noted for its recent 52-week high near $29. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 06, 2026 19:45 WIB: out of 85 priced US Financials stocks tradable on Pluang, 71 rose and 7 fell today. Notable movers include HSBC at USD 98.07 with a 1-day change of +1.44% and Pluang order activity of 46% Sell / 54% Buy, Upstart Holdings Inc at USD 24.70 with a 1-day change of +1.44% and 0% Sell / 100% Buy order activity, and Sezzle Inc at USD 112.36 with a 1-day change of +1.36%.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
